A lifetime of healing patients, understanding how the body heals
itself and endless hours of research and development into the
molecular-level secrets of the human body led to the establishment
of Thione International, Inc. The following is background information
on how a unique Georgia biotechnology company has brought to life
a visionary physician's ideas to help each of us heal ourselves.
History of Thione International and Background
on Theodore Hersh, M.D.
Thione International, Inc. was founded in 1995 and is headquartered
in Atlanta, Georgia. Theodore Hersh, M.D., Professor of Medicine,
Emeritus, Emory University and his wife, Rebecca, launched Thione
based on Dr. Hersh's 30 years of clinical practice and research
experience as a gastroenterologist-hepatologist. One of his many
strengths is a vast knowledge in the field of nutrition and a
keen interest in preventative medicine.
Dr. Hersh graduated from Harvard with a Bachelor of Arts Degree,
Cum Laude, in Biology. He attended medical school at Columbia
University, College of Physicians and Surgeons, in New York City
and had his postgraduate training in Internal Medicine and Gastroenterology
at Mt. Sinai Hospital in New York, The Mayo Clinic in Rochester,
Minnesota, and the Boston City Hospital, Harvard Division, in
During Thione's first four years, the founders focused on designing
formulations, developing applications, conducting patent and clinical
research and submitting patent applications. Those efforts led
to the formation of a technology platform that incorporates sixteen
products supported by considerable scientific research and several
clinical studies performed by independent research laboratories
as well as unaffiliated researchers that support the products.
Following the successful outcome of the research and related studies,
Thione began to commercialize its unique, patented Thione Complex
that is the basis for a growing family of products. The company's
focus was to develop a base of business built on the commercial
efficacy of its technology.
Thione's annual revenue stream supports a proven commercial as
well as clinical efficacy. The company expanded its branding strategy
from a retail perspective to licensing and distribution. Concentrating
on its strengths in application development and scientific research
and development, its licensing and distribution strategy has keyed
on forming alliances with quality partners that provide manufacturing,
marketing and distribution expertise.
Thione's efforts are concentrated on providing the Thione Complex
on a global basis through partnering with companies whose strengths
complement its molecular-level delivery system.
Thione International, Inc. is a healthcare technology company
founded to develop applications utilizing a powerful synergistic
combination of antioxidants consisting of L-glutathione, selenium
and other antioxidants, enzymes and minerals that replicate the
body's cellular antioxidant defense network. The company's patented
compounds and novel delivery methods:
- Prevent damage to cell structure and function
- Protect lipoproteins
- Reduce damage to DNA
L-Glutathione is the body's chief protector and has multiple
functions in disease prevention and in detoxification of chemicals
and drugs. In addition to these capabilities, glutathione acts
as a donor molecule that regenerates oxidized antioxidant compositions
such as vitamins C and E back to their original molecular configuration.
Developed by Dr. Hersh, this biochemical rejuvenation process
forms the basis of the Thione Complex that creates unique
and powerful preventative and therapeutic healthcare applications.
Under his guidance, the company has developed unique applications
and products for various healthcare markets. Concentrating on
its research and development competencies, Thione is developing
both manufacturing and marketing relationships with strategically
selected partners. The company has formed developmental relationships
with several companies. In addition to the core strengths of its
technology, there are other factors that position Thione for worldwide
Management has formulated a vertically integrated strategy in
which it focuses on its core competencies, research and product
development. Thione seeks to demonstrate how its applications
can provide manufacturers with product differentiation by improving
product performance or brand extension.
Results and Collaborations
In addition to its recurring base of business, Thione has formed
relationships with several large tobacco companies and has introduced
its oral care applications to national and international consumer
product organizations, pharmaceutical companies, niche manufacturers
and major distributors.
Platform of Intellectual Property
Thione's intellectual property includes:
- Numerous laboratory and clinical test results
- Trade secrets in the form of manufacturing methods and product
- Eighteen patent applications protecting its compositions and
methods of delivery to the body
- Fifteen of Thione's patent submissions have been granted by
the United States Patent and Trademark Office
- Five have been filed internationally
- The remaining submissions are pending
Development of Advanced Applications
The Company has 16 commercially available product applications
in niche market areas such as:
- Oral care
- Nutriceuticals/Immune System Boosters
- Pain management
The enhancement of existing consumer products, allows Thione
International, Inc. to be highly sought after by many market and
industry segments. The Company's technology and products are highly
beneficial and of global importance.